Amphista Therapeutics discloses first details of its TEAD Targeted Glue™ program and unveils new mechanism of action for TEAD degradation…
FRIENDSWOOD, Texas, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that…
Ad hoc announcement pursuant to Art. 53 LR A conference call will be held on September 23, 2025, at 14:00…
Singapore, Singapore--(Newsfile Corp. - September 23, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or "the Company"), a leading AI-powered…
CHICAGO--(BUSINESS WIRE)--Artisight today announced an enterprise-wide agreement with Yale New Haven Health to implement its Smart Hospital Platform. The initial…
Global AI in Oncology For Analytical Solutions Market to Transform Cancer Care Accelerating Early Detection, Precision Treatment, and Patient Outcomes.…
RELLINGEN, DE / ACCESS Newswire / September 23, 2025 / Viromed Medical AG ("Viromed"; ISIN: DE000A3MQR65), a medical technology company…
Hemogenyx Pharmaceuticals Signs Letter of Intent with Cellin Technologies to Advance Commercialization of HG-CT-1 CAR-T Therapy in EstoniaFirst Potential Near-Term…
VANCOUVER, BC / ACCESS Newswire / September 22, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased…
Connectivity failures, OS updates, and frustrated patients shouldn't be your problem. Silent devices, outsourced call centers, and disengaged patients create…